News
The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...
DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...
HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...
Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...
Proposed Medicaid cuts could threaten lifesaving HIV treatment access, warns Avenue 360. HOUSTON — With President Trump's " ...
The hunt for an HIV treatment that roots the virus out of its hiding places and kills it just got more interesting. New therapy keeps HIV at bay without daily drug regimen, study says - Los ...
Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results